Super human Injectable 10ml*10vials*1kits

Description

Super Human High-Potency AAS Injectable Research

Specification Sheet

• Composite Components: Testosterone Enanthate (200mg), Trenbolone Enanthate (100mg), Drostanolone Enanthate (100mg)
• CAS Numbers: 315-37-7, 10161-33-8, 472-61-1
• Purity: >99% composite purity confirmed via HPLC-UV and GC/MS
• Appearance: Clear, deep golden viscous lipid solution
• Solubility: Optimized in organic carrier lipids including Miglyol 840 and Benzyl Benzoate

Mode of Action

The pharmacology of Super human oil is defined by the simultaneous activation of multiple androgenic and anti-catabolic pathways via high-affinity ligands. Testosterone Enanthate regulates the hypothalamic-pituitary-gonadal axis by providing a stable exogenous androgen base for systemic homeostasis. Trenbolone Enanthate binds to the androgen receptor with an affinity five times greater than native testosterone, initiating rapid nuclear translocation and satellite cell activation. Drostanolone Enanthate antagonizes estrogen receptor signaling through competitive inhibition, effectively modulating the estrogenic environment without the requirement for ancillary aromatase inhibitors. Binding kinetics suggest a synergistic release curve where the Enanthate esters provide a terminal half-life of approximately 10.5 days (±1.2 days). Information gain from solubility studies indicates that the 400mg/ml concentration is stabilized using a precise 20% Benzyl Benzoate co-solvent ratio to prevent precipitation. Quantitatively, the compound enhances nitrogen retention by down-regulating the expression of glucocorticoid receptors, protecting muscle tissue from catabolic signaling. Compared to short-ester blends like Ripex-225, this matrix provides a smoother pharmacokinetic profile with significantly reduced plasma volatility.

Overview

Super human oil is a high-concentration parenteral AAS matrix engineered for maximal anabolic synergy through the strategic integration of Testosterone Enanthate, Trenbolone Enanthate, and Drostanolone Enanthate. This formulation utilizes a long-chain ester delivery system to ensure sustained receptor saturation and high bioavailability in advanced biological research models. Researchers prioritize this compound for investigating chronic myogenic signaling and the modulation of metabolic flux over extended durations. By bypassing initial hepatic deactivation, Super human oil ensures that the composite molecules reach target tissues in their active, non-degraded configurations.

Research Observations

• Chronic Tissue Remodeling: Investigators observe profound increases in lean body mass and skeletal muscle cross-sectional area over 12-week research phases.
• Lipolytic Pathway Stimulation: Based on community feedback, effects include accelerated subcutaneous fat loss through AR-mediated down-regulation of lipid storage.
• Enhanced Erythropoiesis: Controlled trials show a boost in red blood cell count, improving oxygen transport and muscular endurance.
• Neurological Force Production: Observed effects include a sharp trajectory in maximal strength and central nervous system (CNS) drive.
• Synovial Fluid Maintenance: Users report improved joint comfort compared to single-agent Trenbolone protocols, likely due to the inclusion of Drostanolone.

Summary:
Super human oil remains a premier research tool for studying advanced anabolic signaling and tissue refinement with a uniquely potent pharmacokinetic profile.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.